This is the authors' abstract. We don't add key points for this paper.
This paper provides an overview of the context, definition, and key features of the harm reduction approach, and provides several examples of current programs in various countries. Both licit and illicit drugs are included in these illustrations. Some of the critical issues, and the strategies needed to advance harm reduction, are discussed. [Translations are provided in the International Abstracts Section of this issue.]
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Riley et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: